InvestorsHub Logo
Followers 21
Posts 1384
Boards Moderated 0
Alias Born 06/14/2017

Re: daemon57 post# 111620

Thursday, 08/27/2020 10:28:45 AM

Thursday, August 27, 2020 10:28:45 AM

Post# of 232467
I didn't see lenzilumab (HGEN) or RLF-100 (RLFTF) listed either.

Since the former is partnered with Kite (i.e., Gilead) in CAR-T and is doing a combo study with remdesivir (i.e., Gilead) at NIH, I think, in this case at least, it is more of an issue that the ASPH list is incomplete with respect to mAbs rather than leronlimab being excluded intentionally.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News